Susan T. Vadaparampil, PhD, MPH

Susan T. Vadaparampil, PhD, MPH

Susan VadaparampilDr. Vadaparampil’s research uses a combination of behavioral science, epidemiology, health services, and clinical perspectives to understand and improve dissemination and uptake of new cancer prevention and control innovations including genetic testing for hereditary cancer susceptibility and HPV vaccination. Dr. Vadaparampil has successfully obtained grants from both the NIH and the ACS to support her research program. She currently leads an NCI-funded study to examine physician, systems, and policy level factors influencing recommendation of HPV vaccination among a national sample of physicians from three primary care specialties. She recently completed a longitudinal study funded by the ACS to examine the psychosocial impact of genetic testing on recently diagnosed breast cancer patients. Due to a long-standing interest in health disparities, Dr. Vadaparampil also leads and collaborates on several projects to reduce disparities across the cancer prevention and control continuum.

Stay in Touch